Back
Schwab Fundamental U.S. Small CompanyETF Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
91
FNDA
Schwab Fundamental U.S. Small CompanyETF
Last Price:
31.53
Seasonality Move:
4.71%
Buy
74
MIRM
Mirum Pharmaceuticals
Last Price:
42.32
Seasonality Move:
40.11%
Buy
91
Schwab Fundamental U.S. Small CompanyETF (FNDA)
is a Buy
Is Schwab Fundamental U.S. Small CompanyETF a Buy, Sell or Hold?
- The current Schwab Fundamental U.S. Small CompanyETF [FNDA] share price is $31.96. The Score for FNDA is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
- FNDA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
74
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $41.61. The Score for MIRM is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FNDA Stock Price Chart
What is Schwab Fundamental U.S. Small CompanyETF's stock price today?
-
The Schwab Fundamental U.S. Small CompanyETF share price today is $31.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNDA is experiencing slight buying pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $41.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.
FNDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 74.64 | Buy |
| Chaikin Money Flow: | 94618 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.24 - 30.78) | Buy |
| Bollinger Bands (100): | (27.95 - 30.05) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 60.51 | Buy |
| Chaikin Money Flow: | -203992 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.65 - 40.71) | Buy |
| Bollinger Bands (100): | (36.74 - 42) | Buy |
FNDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.57 | Buy |
| 20-day SMA: | 30.13 | Buy |
| 50-day SMA: | 29.58 | Buy |
| 200-day SMA: | 28.27 | Buy |
| 8-day EMA: | 30.93 | Buy |
| 20-day EMA: | 30.29 | Buy |
| 50-day EMA: | 29.72 | Buy |
| 200-day EMA: | 28.3 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.72 | Buy |
| 20-day SMA: | 39.9 | Buy |
| 50-day SMA: | 39.98 | Buy |
| 200-day SMA: | 32.84 | Buy |
| 8-day EMA: | 40.9 | Buy |
| 20-day EMA: | 40.21 | Buy |
| 50-day EMA: | 39.72 | Buy |
| 200-day EMA: | 34.91 | Buy |
Schwab Fundamental U.S. Small CompanyETF Earnings Growth & FNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.71 per share, and an increase next year of $0.88 per share.
Schwab Fundamental U.S. Small CompanyETF Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||